David Roberts's most recent trade in Lemaitre Vascular Inc was a trade of 4 Dividend Equivalent Rights done . Disclosure was reported to the exchange on Sept. 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2025 | 4 | 27 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2025 | 3 | 25 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2025 | 2 | 34 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2025 | 2 | 34 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2025 | 2 | 9 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2025 | 1 | 25 | - | - | Dividend Equivalent Rights | |
| HNI Corp | David M. Roberts | Director | Grant, award, or other acquisition of securities at price $ 44.61 per share. | 12 Aug 2025 | 235 | 6,222 (0%) | 0% | 44.6 | 10,483 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.29 per share. | 11 Aug 2025 | 6,713 | 24,689 (0%) | 0% | 37.3 | 250,328 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2025 | 6,713 | 2,672 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Sale of securities on an exchange or to another person at price $ 92.35 per share. | 11 Aug 2025 | 6,713 | 17,976 (0%) | 0% | 92.4 | 619,978 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2025 | 3,979 | 9,385 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.29 per share. | 11 Aug 2025 | 3,979 | 21,955 (0%) | 0% | 37.3 | 148,377 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Sale of securities on an exchange or to another person at price $ 92.53 per share. | 11 Aug 2025 | 3,718 | 18,360 (0%) | 0% | 92.5 | 344,040 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Sale of securities on an exchange or to another person at price $ 91.55 per share. | 11 Aug 2025 | 384 | 17,976 (0%) | 0% | 91.5 | 35,155 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2025 | 123 | 0 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.48 per share. | 11 Aug 2025 | 123 | 22,078 (0%) | 0% | 35.5 | 4,364 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 5 | 22 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 4 | 22 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 3 | 6 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 3 | 32 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 3 | 31 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 1 | 24 | - | - | Dividend Equivalent Rights | |
| HNI Corp | David M. Roberts | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 2,666 | 5,772 (0%) | 0% | 0 | Common Stock | |
| SPX Technologies Inc | David A. Roberts | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 892 | 40,593 (0%) | 0% | - | Common Stock | |
| HNI Corp | David M. Roberts | Director | Grant, award, or other acquisition of securities at price $ 48.76 per share. | 13 May 2025 | 215 | 5,987 (0%) | 0% | 48.8 | 10,483 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 4 | 17 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 4 | 18 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 3 | 28 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 3 | 27 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 3 | 3 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 1 | 22 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.48 per share. | 07 Mar 2025 | 2,818 | 17,976 (0%) | 0% | 35.5 | 99,983 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 2,818 | 123 | - | - | Stock Option (Right to Buy) | |
| Verra Mobility Corp Ordinary | David Roberts M. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 9,131 | 0 | - | - | Restricted Stock Units | |
| Verra Mobility Corp Ordinary | David Roberts M. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 9,131 | 758,278 (0%) | 0% | 0 | Class A Common Stock | |
| Verra Mobility Corp Ordinary | David Roberts M. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.57 per share. | 04 Mar 2025 | 3,865 | 754,413 (0%) | 0% | 22.6 | 87,233 | Class A Common Stock |
| Verra Mobility Corp Ordinary | David Roberts M. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 86,649 | 785,825 (0%) | 0% | 0 | Class A Common Stock | |
| Verra Mobility Corp Ordinary | David Roberts M. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 58,797 | 58,797 | - | - | Restricted Stock Units | |
| Verra Mobility Corp Ordinary | David Roberts M. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.96 per share. | 03 Mar 2025 | 36,678 | 749,147 (0%) | 0% | 23.0 | 842,127 | Class A Common Stock |
| Verra Mobility Corp Ordinary | David Roberts M. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 16,106 | 705,993 (0%) | 0% | 0 | Class A Common Stock | |
| Verra Mobility Corp Ordinary | David Roberts M. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 16,106 | 16,106 | - | - | Restricted Stock Units | |
| Verra Mobility Corp Ordinary | David Roberts M. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.96 per share. | 03 Mar 2025 | 6,817 | 699,176 (0%) | 0% | 23.0 | 156,518 | Class A Common Stock |
| Verra Mobility Corp Ordinary | David Roberts M. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 15,845 | 696,594 (0%) | 0% | 0 | Class A Common Stock | |
| Verra Mobility Corp Ordinary | David Roberts M. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 15,845 | 31,690 | - | - | Restricted Stock Units | |
| Verra Mobility Corp Ordinary | David Roberts M. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 13,112 | 686,402 (0%) | 0% | 0 | Class A Common Stock | |
| Verra Mobility Corp Ordinary | David Roberts M. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 13,112 | 39,335 | - | - | Restricted Stock Units | |
| Verra Mobility Corp Ordinary | David Roberts M. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.89 per share. | 01 Mar 2025 | 6,707 | 689,887 (0%) | 0% | 22.9 | 153,523 | Class A Common Stock |
| Verra Mobility Corp Ordinary | David Roberts M. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.89 per share. | 01 Mar 2025 | 5,653 | 680,749 (0%) | 0% | 22.9 | 129,397 | Class A Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 685 | 15,356 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.85 per share. | 28 Feb 2025 | 203 | 15,158 (0%) | 0% | 91.9 | 18,646 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 5 | 12 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 5 | 15,361 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 741 | 741 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 129 | 14,671 (0%) | 0% | 0 | Common Stock | |
| HNI Corp | David Roberts M. | Director | Grant, award, or other acquisition of securities at price $ 48.23 per share. | 12 Feb 2025 | 215 | 3,106 (0%) | 0% | 48.2 | 10,369 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.12 per share. | 20 Dec 2024 | 115 | 14,542 (0%) | 0% | 92.1 | 10,594 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2024 | 17 | 14,657 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | Roberts B. David | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2024 | 17 | 2 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | Roberts David B. | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.28 per share. | 11 Dec 2024 | 197 | 14,837 (0%) | 0% | 100.3 | 19,755 | Common Stock |
| Lemaitre Vascular Inc | B. David Roberts | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.28 per share. | 11 Dec 2024 | 197 | 14,640 (0%) | 0% | 100.3 | 19,755 | Common Stock |
| Lemaitre Vascular Inc | B. David Roberts | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.00 per share. | 11 Dec 2024 | 196 | 15,012 (0%) | 0% | 101 | 19,796 | Common Stock |
| Lemaitre Vascular Inc | B. David Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 18 | 15,208 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 18 | 20 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | B. Roberts David | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 11 | 15,034 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | B. David Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 11 | 15,023 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | Roberts B. David | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 11 | 25 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | B. David Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 11 | 24 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.12 per share. | 09 Dec 2024 | 169 | 15,190 (0%) | 0% | 101.1 | 17,089 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 4 | 15,359 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 4 | 13 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 7,662 | 7,662 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 1,335 | 15,355 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 3 | 36 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 3 | 17 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 3 | 35 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 2 | 38 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.47 per share. | 02 Dec 2024 | 106 | 14,020 (0%) | 0% | 105.5 | 11,180 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 12 | 14,126 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 12 | 14 | - | - | Dividend Equivalent Rights | |
| HNI Corp | David Roberts | Director | Grant, award, or other acquisition of securities at price $ 54.84 per share. | 08 Nov 2024 | 189 | 2,891 (0%) | 0% | 54.8 | 10,365 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 4 | 14 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 3 | 33 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 3 | 32 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 2 | 36 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 1 | 26 | - | - | Dividend Equivalent Rights | |
| Verra Mobility Corp Ordinary | David Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 77,520 | 38,760 | - | - | Employee Stock Option (Right to Buy) | |
| Verra Mobility Corp Ordinary | David Roberts | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 27.00 per share. | 13 Aug 2024 | 77,520 | 673,290 (0%) | 0% | 27 | 2,093,040 | Class A Common Stock |
| Verra Mobility Corp Ordinary | David Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.69 per share. | 13 Aug 2024 | 77,520 | 750,810 (0%) | 0% | 13.7 | 1,061,249 | Class A Common Stock |
| Verra Mobility Corp Ordinary | David Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 51,498 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Verra Mobility Corp Ordinary | David Roberts | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 27.01 per share. | 13 Aug 2024 | 51,498 | 673,290 (0%) | 0% | 27.0 | 1,390,940 | Class A Common Stock |
| Verra Mobility Corp Ordinary | David Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.62 per share. | 13 Aug 2024 | 51,498 | 724,788 (0%) | 0% | 12.6 | 649,905 | Class A Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Sale of securities on an exchange or to another person at price $ 82.07 per share. | 13 Aug 2024 | 3,063 | 14,114 (0%) | 0% | 82.1 | 251,380 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 2,941 | 2,941 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.48 per share. | 13 Aug 2024 | 2,941 | 17,177 (0%) | 0% | 35.5 | 104,347 | Common Stock |
| HNI Corp | David Roberts | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 2,288 | 2,702 (0%) | 0% | 0 | Common Stock | |
| HNI Corp | David Roberts | Director | Grant, award, or other acquisition of securities at price $ 50.07 per share. | 13 Aug 2024 | 414 | 414 (0%) | 0% | 50.1 | 20,729 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.56 per share. | 13 Aug 2024 | 122 | 14,236 (0%) | 0% | 23.6 | 2,874 | Common Stock |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 122 | 0 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 4 | 10 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 4 | 28 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 4 | 29 | - | - | Dividend Equivalent Rights |